ROBIN HOWARD W — SEC Form 4 filings
SEC reporting owner CIK 1206869. 19 Form 4 filings on record with FilingPulse; latest filed 2026-08-20.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-02-22 to 2026-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 16 filings — 291,917 shares, $2,503,603 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 5,500 shares @ $60.81 ($334,455) in NEKTAR THERAPEUTICS, filed 2026-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | President & CEO, Director | 19 | — | 29 legs · 291,917 sh · $2,503,603 | 9 |
Form 4 filings — ROBIN HOWARD W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 418 @ $71.98 | EDGAR |
| 2026-07-24 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 57,200 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 5,303 @ $59.97 · Sale (S): 4,697 @ $60.71 · Sale (S): 5,500 @ $60.81 · Sale (S): 4,500 @ $61.65 | EDGAR |
| 2026-05-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 444 @ $65.51 | EDGAR |
| 2026-02-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 423 @ $73 | EDGAR |
| 2025-12-23 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 21,667 @ $0 · Grant/award (A): 86,667 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 7,110 @ $0 · Sale (S): 2,207 @ $54.28 · Grant/award (A): 12,170 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 2,100 @ $45.16 · Sale (S): 1,200 @ $46.41 · Sale (S): 2,156 @ $47.49 · Sale (S): 1,210 @ $48.18 | EDGAR |
| 2025-09-08 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 1,923 @ $32.37 · Sale (S): 1,496 @ $33.54 · Sale (S): 613 @ $34.40 · Sale (S): 1,134 @ $35.80 · Sale (S): 3,304 @ $37.87 · Sale (S): 2,226 @ $38.82 · +1 more | EDGAR |
| 2025-09-04 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 1,500 @ $30.16 | EDGAR |
| 2025-08-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 1,573 @ $26.59 · Grant/award (A): 86,666 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 23,208 @ $0.67 | EDGAR |
| 2025-02-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 23,774 @ $1.01 | EDGAR |
| 2024-12-19 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 46,995 @ $1.01 · Sale (S): 85,035 @ $0.99 | EDGAR |
| 2024-12-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 410,625 @ $0 · Grant/award (A): 821,250 (derivative) @ $0 · Grant/award (A): 1,300,000 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 16,278 @ $1.01 | EDGAR |
| 2024-08-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 14,881 @ $1.28 | EDGAR |
| 2024-05-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 16,650 @ $1.75 | EDGAR |
| 2024-02-22 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 20,033 @ $0.68 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1206869 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →